Comparing the Effectiveness and Complications of Sodae and Sodium Valproate on Migraine
Publish place: Caspian Journal of Neurological Sciences، Vol: 9، Issue: 4
Publish Year: 1402
نوع سند: مقاله ژورنالی
زبان: English
View: 75
This Paper With 9 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_CJNS-9-4_003
تاریخ نمایه سازی: 29 آذر 1402
Abstract:
Background: Sodium valproate is recommended as a first-line drug to prevent migraine attacks,
and sodae is an herbal medicine.
Objectives: Sodium valproate and herbal Sodae were compared for effectiveness and side effects.
Materials & Methods: A two-center, randomized, double-blind clinical trial included migraine
patients from Kermanshah and Hamadan cities into two groups: Sodae herbal recipients and
valproate (۲۰۰ mg) recipients, for ۳ months. A numerical rating scale (NRS) scale was used to
measure residual pain at the end of each month of treatment. Also, a researcher-made form and the
headache impact test (HIT-۶) questionnaire were used. Side effects reported by the patients were
collected, and liver function tests and complete blood cell count tests were conducted.
Results: A total of ۷۰ migraine patients were evaluated: ۳۳ patients (۴۷%) in the Soda group and ۳۷
patients (۵۳%) in the valproate group. The NRS scores in both groups decreased constantly, with no
significant difference (P=۰.۳۰۳). Also, HIT-۶ scores were constantly reduced in both groups with
no significant difference (P>۰.۰۵). More side effects are significantly (P=۰.۰۴۳) reported in the
valproate group (۵۴.۰۵%) than in the Sodae group (۳۰.۳۰%). The most common side effect in the
valproate group was drowsiness (۱۳.۵%), while among the sodae group, it was diarrhea (۱۵.۱%).
Conclusion: The sodae and valproate did not differ in headache improvement, HIT-۶ scores, and
changes in laboratory parameters. However, the valproate group reported more side effects than the
Sodae group. Sodae is a suitable herbal medicine for preventing and controlling migraine attacks.
Keywords:
Authors
Mansour Rezaei
Department of Biostatistics, Social Development and Health Promotion Research Center, School of Health, Research Institute for Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
Negin Fakhri
Student’s Research Committee, School of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
Daryoush Afshari
Department of Neurology, Imam Reza Hospital, School of Medicine, Kermanshah University of Medical Science, Kermanshah, Iran
Mojtaba Khazaei
Department of Neurology, Sina (Farshchian) Educational and Medical Center, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran